Quarterly report pursuant to Section 13 or 15(d)

Warrants (Tables)

v3.21.2
Warrants (Tables)
9 Months Ended
Sep. 30, 2021
Convertible Notes Payable  
Schedule of warrant

 

 

Number of

Shares

 

 

Weighted

Average

Exercise

Price

 

 

Weighted

Average

Remaining Contractual

Life (years)

 

 

Aggregate

Intrinsic

Value

 

 

 

 

 

 

 

 

 

 

 

 

 

 

January 1, 2021

 

 

5,595,378

 

 

$ 0.63

 

 

 

2.85

 

 

$ 314,260

 

Grants

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

Exercises

 

 

(1,030,166 )

 

$ 0.42

 

 

 

-

 

 

 

-

 

Expirations

 

 

(280,212 )

 

$ 0.35

 

 

 

-

 

 

 

-

 

September 30, 2021

 

 

4,285,000

 

 

$ 0.70

 

 

 

2.72

 

 

$ -

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercisable at:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

September 30, 2021

 

 

4,285,000

 

 

$ 0.70

 

 

 

2.72

 

 

$ -

 

Summary of common stock warrants outstanding

Outstanding and Exercisable

Exercise Price

 

 

Number Outstanding

 

 

Weighted Average

Remaining

Contractual

Life (years)

 

 

Weighted Average

Exercise Price

 

$

0.70

 

 

 

4,285,000

 

 

 

2.72

 

 

$ 0.70

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

$

0.70

 

 

 

4,285,000

 

 

 

2.72

 

 

$ 0.70